Clinical Trials Directory

Trials / Unknown

UnknownNCT03383796

Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Randomized Clinical Trial Comparing Three Dimension Laparoscopic and Open Surgery for Perihiliar Cholangiocarcinoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Cholangiocarcinoma (CCA) is the most common biliary tract malignancy and the second most common primary hepatic malignancy. The prognosis of CCA is dismal. Surgery is the only potentially curative treatment, but the majority of patients present with advanced stage disease, and recurrence after resection is common. It is classified into intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes. Among all, pCCA is the most common subtype. This is a prospective, randomized, controlled multicenter trial with two treatment arms, three dimension laparoscopic approach versus open approach. The trial hypothesis is that three dimension laparoscopic surgery has advantages in postoperative recoveries and be equivalent in operation time, oncological results and long-term follow-up compared with open counterpart. The duration of the entire trial is two years including prearrangement, follow-up and analyses.

Conditions

Interventions

TypeNameDescription
PROCEDUREThree dimensional laparoscopic resection for pCCAThree dimensional laparoscopic resection for pCCA
PROCEDUREOpen resection for pCCAOpen resection for pCCA

Timeline

Start date
2018-03-01
Primary completion
2021-03-01
Completion
2022-03-01
First posted
2017-12-26
Last updated
2020-10-08

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03383796. Inclusion in this directory is not an endorsement.